{"schema":"pith.reference-change-event.v1","doi":"10.1038/s41591-020-0840-5","canonical_url":"https://pith.science/event/10.1038/s41591-020-0840-5","json_url":"https://pith.science/event/10.1038/s41591-020-0840-5.json","not_a_judgment":"This page records that a citing paper's bibliography includes a work with a published notice. It is not a judgment on the citing paper.","primary":{"event_id":176025,"doi":"10.1038/s41591-020-0840-5","event_type":"correction","event_type_label":"Correction","source":"crossref","source_label":"Crossref","event_date":"2020-06-18","title":"Publisher Correction: Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer","work_title":null,"work_doi":"10.1038/s41591-020-0840-5","work_arxiv_id":null,"notice_doi":"10.1038/s41591-020-0973-6","flag_count":0,"flags_open":0,"flags_disputed":0,"latest_flag_at":null,"human_href":"/event/10.1038/s41591-020-0840-5","json_href":"/event/10.1038/s41591-020-0840-5.json"},"events":[{"event_id":176025,"doi":"10.1038/s41591-020-0840-5","event_type":"correction","event_type_label":"Correction","source":"crossref","source_label":"Crossref","event_date":"2020-06-18","title":"Publisher Correction: Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer","work_title":null,"work_doi":"10.1038/s41591-020-0840-5","work_arxiv_id":null,"notice_doi":"10.1038/s41591-020-0973-6","flag_count":0,"flags_open":0,"flags_disputed":0,"latest_flag_at":null,"human_href":"/event/10.1038/s41591-020-0840-5","json_href":"/event/10.1038/s41591-020-0840-5.json"}],"flags":[{"id":8533,"status":"open","status_label":"Open","citing_arxiv_id":"2508.20130","citing_title":"Artificial Intelligence for CRISPR Guide RNA Design: Explainable Models and Off-Target Safety","ref_index":29,"evidence_raw":"Lu, Y., Xue, J., Deng, T., Zhou, X., Yu, K., Deng, L., Huang, M., Yi, X., Liang, M., Wang, Y., Shen, H., Tong, R., Wang, W., Li, L., Song, J., Li, J., Su, X., Ding, Z., Gong, Y., Zhu, J., Wang, Y., Zou, B., Zhang, Y., Li, Y., Zhou, L., Liu, Y., Yu, M., Wang, Y., Zhang, X., Yin, L., Xia, X., Zeng, Y., Zhou, Q., Ying, B., Chen, C., Wei, Y., Li, W., Mok, T.: Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer. Nat. Med. 26(5), 732–740 (2020). DOI 10.1038/s41591-020-0840-5","evidence_cleaned":null,"evidence_source_label":"bibliography line","event_type":"correction","event_type_label":"Correction","source_label":"Crossref","event_date":"2020-06-18","work_title":null,"work_doi":"10.1038/s41591-020-0840-5","event_doi":"10.1038/s41591-020-0840-5","flag_href":"/flags/8533","event_href":"/event/10.1038/s41591-020-0840-5","paper_href":"/paper/2508.20130","created_at":"2026-08-05T18:20:22.354982Z","dispute_note":null,"disputed_at":null,"disputed_by":null}],"flag_count":1,"flags_open":1,"flags_disputed":0,"desk_url":"https://pith.science/flags"}